Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
about
Human placental Na+,K+-ATPase alpha subunit: cDNA cloning, tissue expression, DNA polymorphism, and chromosomal localizationFully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancersPharmacogenetic heterogeneity of transgene expression in muscle and tumoursNuclear receptor response elements mediate induction of intestinal MDR1 by rifampinImproved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposureFrameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.Genetics and biochemistry of collagen binding-triggered glandular differentiation in a human colon carcinoma cell line.Evolutionary history and functional characterization of the amphibian xenosensor CAR.Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab.Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.p53 mutations in colorectal cancerBilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases.Pregnane X receptor and yin yang 1 contribute to the differential tissue expression and induction of CYP3A5 and CYP3A4.Matrix-insensitive protein assays push the limits of biosensors in medicine.Impact of α-targeted radiation therapy on gene expression in a pre-clinical model for disseminated peritoneal disease when combined with paclitaxel.Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.Nuclear legumain activity in colorectal cancer.Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol-specific phospholipase CMicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation.PI3-kinase activation is critical for host barrier permissiveness to Listeria monocytogenes.Human biosample authentication using the high-throughput, cost-effective SNPtrace(TM) system.Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease.Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3Induction of expression and functional activity of P-glycoprotein efflux transporter by bioactive plant natural products.VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.Properties of a cell line from human adenocarcinoma of the rectum.The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
P2860
Q24633196-7ED28599-EF9D-4B96-910E-834368EEDC42Q24792155-73817230-69E0-4D60-AFE3-80D016F4FBE4Q24799710-37D04CDB-17D0-4110-B018-0BF4FA6E54A4Q28211706-C5A3D55F-8F64-474B-ADD5-791826402023Q28272255-BE04430A-E73D-4EFA-A7E2-A5CE2B8D33C8Q28366014-4E59B167-0D90-4C88-83DB-A04CA27B56B1Q33383621-F621127A-B21D-45B4-B590-E7DE4A5AF12DQ33611147-A3CF21D4-FBAC-4A99-B27C-0547D9CA1DD9Q33635718-FDA33E22-0D79-4DAE-9D39-CF5952A74D34Q33636734-4441E897-B0D3-4B5F-9913-99A6C8D08022Q33661325-FF0FE83A-0C0A-47E9-9CE8-2E033B919980Q33761180-2453D323-367A-4244-B155-91C2D943F4D5Q33786764-75D056C3-6F86-417E-BBAB-6C59897A2B2FQ33818791-9E64FFE8-B2B3-4A22-9D64-A3E870FAFF3EQ33825288-6275DE41-7314-4536-A164-0CAD4832E4DDQ34075225-97E1A329-250D-4F16-A829-2173B0B58707Q34110695-AA59E57B-74C1-40E4-9FFD-D4852930AF12Q34146529-9D30FCC8-7F8C-4B3E-83E7-14F3757A0203Q34194252-5AE5AD31-E14F-4C83-AD11-1468B0F9AE02Q34277296-A105E93B-D1D1-42AE-933F-4D5E5A95D6B7Q34343317-0FAFC440-6028-4149-8E4B-DB2189F38FC0Q34551087-72AAE480-CC58-41CF-93D4-25A4D081669DQ34559983-423F4AD1-9735-4B5D-A623-7D297DD9004AQ34774540-8A5C35FF-870A-4DAD-8635-0AE815703078Q34838011-60C32AAF-67C9-48EC-A8F1-151A97ADFF0FQ35064911-22CCF029-0ED3-4476-9B8F-4AF229F53032Q35122895-10BD0CD0-20DD-4D35-9A78-0ECD0F0DBB4DQ35184647-A5DD93E5-D1CA-41E6-81D8-4AC44EEC05D6Q35212135-57E69F4C-5C0F-4544-9A13-2EC95F540F5EQ35227038-2E01D963-2C8A-4484-9370-620C94ABBB7DQ35301130-744AECBE-8B79-4E46-ADDE-34001F6A5763Q35640677-7433B525-DE82-4D7F-940F-818A4F150C65Q35650273-406E483B-0048-4449-AA76-959F39F57413Q35815494-1285A11D-F079-4162-9457-0140EB4350ABQ35820342-479964DC-2B17-43E1-8175-758029219638Q35832746-2B1ADC9A-68FA-4E23-A9EA-15C5391F5EB2Q35976169-17EFF887-8496-45DF-978A-9E1F333EE21CQ35977748-A6A2EFF7-864C-4D09-860B-E779990E8A11Q36069380-D21FD029-BE28-4091-BE19-976377459740Q36080676-E40CCA02-C461-4800-A8BF-5969AB7C5C50
P2860
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@en
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@nl
type
label
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@en
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@nl
prefLabel
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@en
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@nl
P2093
P356
P1433
P1476
Human colonic adenocarcinoma cells. I. Establishment and description of a new line.
@en
P2093
P304
P356
10.1007/BF02796440
P577
1976-03-01T00:00:00Z